NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/11/2022
Back to search
Official data from USPTO
C² PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
10/11/2022
Trademark type
Combined
Nice classes
1
Filing date
12/19/2017
Registration date
10/11/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/11/2022
Last transaction
10/11/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/06/2017
First use in commerce
10/06/2017
Drawing code
3
Owner type
16
Owner location
Luxembourg, LU
Examiner
ELTON, DAVID JONATHAN
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a green leaf design in a green hexagon shape to the left of the wording "C2 PHARMA" in green, with the "2" in superscript. The color white represents background or transparent areas and is not part of the mark.
Holders and representatives
Holders
C. R. (pessoa física)
Representatives
Robert W. Sacoff PATTISHALL MCAULIFFE NEWBURY HILLIARD & GERALDSON
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating a wide variety of diseases and disorders; chemical compounds for use in the manufacture of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
58 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/11/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/07/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/06/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/24/2022
IUAF
USE AMENDMENT FILED
08/22/2022
EISU
TEAS STATEMENT OF USE RECEIVED
08/22/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/01/2022
EX5G
SOU EXTENSION 5 GRANTED
01/31/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/31/2022
EXT5
SOU EXTENSION 5 FILED
01/24/2022
EEXT
SOU TEAS EXTENSION RECEIVED
01/24/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/20/2021
EX4G
SOU EXTENSION 4 GRANTED
07/16/2021
EXT4
SOU EXTENSION 4 FILED
07/16/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/16/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/05/2021
EX3G
SOU EXTENSION 3 GRANTED
02/03/2021
EXT3
SOU EXTENSION 3 FILED
02/03/2021
EEXT
SOU TEAS EXTENSION RECEIVED
02/03/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/12/2020
EX2G
SOU EXTENSION 2 GRANTED
08/10/2020
EXT2
SOU EXTENSION 2 FILED
08/10/2020
EEXT
SOU TEAS EXTENSION RECEIVED
08/10/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/14/2020
EX1G
SOU EXTENSION 1 GRANTED
02/12/2020
EXT1
SOU EXTENSION 1 FILED
02/12/2020
EEXT
SOU TEAS EXTENSION RECEIVED
02/12/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/20/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/25/2019
PUBO
PUBLISHED FOR OPPOSITION
06/25/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/05/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/23/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
05/23/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/23/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
05/23/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/23/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/14/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/14/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/14/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/17/2018
GNFR
FINAL REFUSAL E-MAILED
11/17/2018
CNFR
FINAL REFUSAL WRITTEN
11/17/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/23/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/23/2018
ALIE
ASSIGNED TO LIE
10/22/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/27/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/06/2018
GNRT
NON-FINAL ACTION E-MAILED
04/06/2018
CNRT
NON-FINAL ACTION WRITTEN
04/06/2018
DOCK
ASSIGNED TO EXAMINER
03/28/2018
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
02/13/2018
ALIE
ASSIGNED TO LIE
02/09/2018
ALIE
ASSIGNED TO LIE
02/07/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
01/29/2018
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/05/2018
NWAP
NEW APPLICATION ENTERED
12/22/2017
Continuous trademark protection
Get notified about every new filing that threatens C² PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.